Skip to content

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

HIV treatment reduces risk of TB in South Africa more than previously thought

HIV viral load in semen increased by CMV in the genital tract

Condoms reduce genital herpes risk for both men and women

Pfizer releases further details of liver toxicity in maraviroc study

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems

Inherited genetic variation of the chemokine receptor CX3CR1 more common in long-term non-progressors

Ranbaxy announces new co-packaged triple ART combinations